Of AVA group, multivariate Cox regression analysis for MAE-free survival by preoperative echocardiographic parameters.

<p>Of AVA group, multivariate Cox regression analysis for MAE-free survival by preoperative echocardiographic parameters.</p

Clinical characteristics and echocardiographic parameters^a.

<p>Clinical characteristics and echocardiographic parameters<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0148278#t001fn001" target="_blank">^a</a>.</p

Preoperative-and-postoperatively pairwise comparison of echocardiographic abnormalities.

<p>Preoperative-and-postoperatively pairwise comparison of echocardiographic abnormalities.</p

Preoperative parameters and their associations with worsening of NYHA functional class.

<p>Preoperative parameters and their associations with worsening of NYHA functional class.</p

Additional file 1: Table S 1.1. of Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients

Comparison of demographics and clinical variables among ED subtypes. Table S 1.2. Comparison of lifetime psychiatric diagnoses between ED subtypes. (DOCX 32 kb

Flow chart of study procedures.

<p>From eligible 4,320 cycles with the initial criteria of fresh ET, 480 cycles met the Bologna criteria of POR. Finally, 156 cycles were selected after screening with exclusion criteria. At every follow-up visit, regular evaluations and assessments were made in both groups.Totally, 156 cycles with POR received fresh ET using LPS consisting of three doses of hCG (1500IU) plus Crinone 90 mg qd beginning 2 days after OPU were included in this study. One hundred cycles were in the study group with early stop of progesterone and 56 were in the control group without early stop. There were no statistically significant differences observed in baseline characteristics between two groups, as age (39.5 ± 3.8 vs. 39.9 ± 3.1 year; P = 0.51), body mass index (BMI) (21.8 ± 2.5 vs. 22.3 ± 2.8 kg/m2; P = 0.34), causes of infertility (P = 0.91), gravida (0.91 ± 1.1.5 vs. 0.96 ± 0.94; P = 0.77), parity (0.25 ± 0.55 vs. 0.16 ± 0.41; P = 0.26), previous artificial abortion (0.14 ± 0.37 vs. 0.21 ± 0.49; P = 0.33), spontaneous abortion (0.48 ± 0.79 vs. 0.52 ± 0.71; P = 0.77) and ectopic pregnancy (0.05 ± 0.26 vs. 0.04 ± 0.19; P = 0.69). The general demographics of the patient cohort are listed below (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0201824#pone.0201824.t001" target="_blank">Table 1</a>).</p

Overall reproductive outcomes in multivariate analysis.

<p>Overall reproductive outcomes in multivariate analysis.</p

Pregnancy outcomes for the early stop of progesterone supplement and control groups.

<p>Pregnancy outcomes for the early stop of progesterone supplement and control groups.</p

IVF characteristics of the two groups with early stop of progesterone or continuation.

<p>IVF characteristics of the two groups with early stop of progesterone or continuation.</p